Birdwatch Archive

Birdwatch Note Rating

2024-06-16 20:00:18 UTC - NOT_HELPFUL

Rated by Participant: 5243B040823C864DA2D85EA348BB2F99D73DD7BA7C5D4B3F362B17DF3819B730
Participant Details

Original Note:

AstraZeneca lowered the price of their inhalers to remain competitive with other manufacturers. This was not mandated. https://thehill.com/policy/healthcare/4539276-astrazeneca-follows-rival-will-cap-inhaler-prices-at-35-per-month-amid-scrutiny/

All Note Details

Original Tweet

All Information

  • noteId - 1802425101255672002
  • participantId -
  • raterParticipantId - 5243B040823C864DA2D85EA348BB2F99D73DD7BA7C5D4B3F362B17DF3819B730
  • createdAtMillis - 1718568018320
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 18024251012556720025243B040823C864DA2D85EA348BB2F99D73DD7BA7C5D4B3F362B17DF3819B730